Drug commercialization

Cogent Biosciences is a biotechnology company developing precision therapies for genetically driven diseases. It focuses on rational precision therapies leveraging validated biology to address underlying drivers of disease, with a discovery organization in Boulder, Colorado pioneering small molecule therapeutics. Its lead therapy is bezuclastinib, being developed for systemic mastocytosis and GIST.

Read more

clinical developmentsmall molecule drug discovery

of page OUR SERVICESFUNDRAISING AND INVESTMENT Provide seed funding Angel investing Investment Due Diligence Institutional investment assistance BUSINESS PLAN DEVELOPMENT Virtual management team Develop business plan Strategic planning Project management Product licensing and Due Diligence Advice and expertise to help improve business performance DRUG COMMERCIALIZATION Specific guidance in terms of operations, supply chain, profitability, management, structure and strategy Expertise to analyze customer insights, brand performance, market trends and competitive response to inform overall strategic plan Financial aptitude to manage spend and coordination of investments across functions Knowledge to ensure compliance with relevant laws, regulations and standards of business conduct and ethics DRUG DEVELOPMENT Oversight of Due Diligence on in-licensing opportunities Research and development.

Read more

business plan developmentclinical trial managementdrug developmentexpert testimonyFundraising and investmentLitigation support servicesMediation and arbitrationmedical writingRegulatory and clinical services